GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medacta Group SA (XSWX:MOVE) » Definitions » Institutional Ownership

Medacta Group (XSWX:MOVE) Institutional Ownership : 15.04% (As of Dec. 13, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Medacta Group Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Medacta Group's institutional ownership is 15.04%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Medacta Group's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Medacta Group's Float Percentage Of Total Shares Outstanding is 0.00%.


Medacta Group Institutional Ownership Historical Data

The historical data trend for Medacta Group's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medacta Group Institutional Ownership Chart

Medacta Group Historical Data

The historical data trend for Medacta Group can be seen below:

2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30
Institutional Ownership 15.72 15.21 15.17 15.46 15.36 15.20 15.32 15.07 15.14 15.04

Medacta Group Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Medacta Group Business Description

Traded in Other Exchanges
Address
Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874
Medacta Group SA is a Switzerland based company involved in developing, manufacturing and distributing orthopedic and neurosurgical medical devices. The company offers solutions for Hip, Knee, Shoulder and Spine. The majority of the company's revenue is generated from Europe, Middle East, and Africa (EMEA) and the rest from other regions.